Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,574,340,467
New position
Shares Held
28,264,580
first reported quarter
Ownership
1.82%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.60686484639079.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3931351536092169.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital World Investors holds $43,445,551,682 across 10 Drug Manufacturers - General names. AZN ranks #4 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,621,813 | $14,368,474,943 | |
| 2 | AMGN |
Amgen Inc
|
29,288,343 | $10,305,103,484 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
41,283,933 | $5,753,741,742 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
28,264,580 | $5,574,340,467 | |
| 5 | ABBV |
AbbVie Inc.
|
15,841,367 | $3,445,338,908 | |
| 6 | JNJ |
Johnson & Johnson
|
11,749,361 | $2,872,013,802 | |
| 7 | PFE |
Pfizer Inc
|
21,947,486 | $616,285,406 | |
| 8 | NVO |
Novo Nordisk A S
|
5,209,427 | $191,446,442 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,574,340,467 | 28,264,580 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||